Skip to main content
Clinical Trials/NCT04064229
NCT04064229CompletedNot Applicable

ivWatch Sensor: Device Validation for Infiltrated Tissues

ivWatch, LLC1 site in 1 country99 target enrollmentStarted: April 3, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
99
Locations
1
Primary Endpoint
Red Notification Sensitivity to Infiltrated Tissues

Study Overview

Brief Summary

A single arm trial consisting of 98 adult volunteers to assess the safety and efficacy of ivWatch sensors when observing infiltrated tissues at common sites for peripheral IV therapy.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Informed Consent
  • •Pass health screen by clinician
  • •18 years or older

Exclusion Criteria

  • •Fail health screen

Arms & Interventions

Infiltrated Tissue

Experimental

The ivWatch Model 400 sensors monitored an IV site during the infiltration of 10 mL of isotonic saline solution. IV sites were placed in the forearm and the dorsal aspect of the hand. The rate of the infiltration ranged between 5 mL/hr to 150 mL/hr.

Intervention: ivWatch Model 400 with SmartTouch Sensor (Device)

Infiltrated Tissue

Experimental

The ivWatch Model 400 sensors monitored an IV site during the infiltration of 10 mL of isotonic saline solution. IV sites were placed in the forearm and the dorsal aspect of the hand. The rate of the infiltration ranged between 5 mL/hr to 150 mL/hr.

Intervention: ivWatch Model 400 with Fiber Optic Sensor (Device)

Outcomes

Primary Outcomes

Red Notification Sensitivity to Infiltrated Tissues

Time Frame: After each participant has been infiltrated, an expected average of 1 hour

The ratio of the number of infiltrated IV sites where the ivWatch Model 400 device issued a red notification to the total number of infiltrated IV sites in the study. All infiltrations were limited to 10 mL of isotonic saline solution.

Secondary Outcomes

  • Yellow Notification Sensitivity to Infiltrated Tissues(After each participant has been infiltrated, an expected average of 1 hour)
  • Infiltrated Volume When Red Notification Issued(After each participant has been infiltrated, an expected average of 1 hour)
  • Infiltrated Volume When Yellow Notification Issued(After each participant has been infiltrated, an expected average of 1 hour)
  • Significant Skin Irritation or Disruption to Skin Integrity(After each participant has been infiltrated, an expected average of 1 hour)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials